A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

Introduction. Gemcitabine and cisplatin (GC) is a gold-standard first-line systemic chemotherapy for advanced urothelial carcinoma (UC). However, it may cause severe adverse effects such as renal toxicity, gastrointestinal toxicity, and neurotoxicity. Sarcopenia is the age-related loss of skeletal m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomed Res Int
Main Authors: Kasahara, Ryo, Kawahara, Takashi, Ohtake, Shinji, Saitoh, Yoko, Tsutsumi, Sohgo, Teranishi, Jun-ichi, Miyoshi, Yasuhide, Nakaigawa, Noboru, Yao, Masahiro, Kobayashi, Kazuki, Uemura, Hiroji
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406717/
https://ncbi.nlm.nih.gov/pubmed/28497065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7981549
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados